FolioLanternBeta
ESTAEstablishment Labs Holdings Inc. · Insider ownership research

Establishment Labs Holdings Inc. insiders sold $22.9M in the past 12 months. How much of their stake is that?

100% was sold under disclosed trading plans. The largest seller, Quiros Chacon (Director), sold $22.9M.Share-of-stake figures for this company are being verified and will be added when that check is finished. Why

Updated Oct 16, 2026 from SEC filings · covers Oct 17, 2025 to Oct 16, 2026
$22.9M
largest seller, Quiros Chacon, past 12 months
100%
of sales were under disclosed trading plans, past 12 months
1 of 10
officers and directors sold shares, past 12 months
Is this normal? More than usual: $22.9M sold, after almost none in the past 5 years. 1 insider sold; the average is 2 a year. Year by year
Latest filing: Filed Oct 2 for a stock award on Sep 30. Nicholas Lewin received an award of 389 shares. Filing
SEC ownership filings: 52 filed in the 12 months to Oct 16, 2026; 301 on record since Jul 18, 2018 · See the evidence

What stands out

Routine activity: 100% of sales were under disclosed plans, and no insider sold more than 1% of vested holdings.

A share of stake is shown for 0 of the 1 officer or director who sold. 10 are left out

i
Left out: Quiros Chacon, Nicholas Lewin, Edward Schutter, Filippo Caldini, Bryan Slotkin, Ann Custin, Leslie Gillin, Samuel Mansbach, Cassandra Harris and Taylor Harris (share of stake is being verified).
Disclosed company stock is not an insider's whole wealth.

Who sold, and how much of their stake

Officers and directors, past 12 months. Their share of stake is being verified and is not shown yet; amounts and trading plans are below.

Quiros Chacon
Director
Not confirmed
Share of stake not shown: share of stake is being verified. Why
$22.9MDisclosed plan
Amounts, filings and trading plans for each seller

Selling by month

Officers and directors, Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planOne dollar scale for every month; the tallest bar is labeled
OctNovDecJanFebMar 2026: $2.3M under a disclosed planMarApr 2026: $7.4M under a disclosed planAprMay 2026: $13.2M under a disclosed plan$13.2MMayJunJulAugSepOct

Recent activity

Past 30 days, Sep 17, 2026 to Oct 16, 2026

No officer or director trades were reported for the past 30 days. The most recent before that:

Aug 20, 2026Filippo Caldini had 682 shares ($49K) withheld by the company for taxes (not a market sale).
WhoSharesPrice% of total stakeTotal stake afterTrade dateFiled
Filippo Caldini
Chief Executive Officer, Director
682$71.52n/an/aAug 20, 2026Aug 26, 2026

Outside holders, reported separately

JW Asset Management, LLC sold $14.0M in the past 12 months. Large shareholders and the funds or companies that board members represent are not part of management, so they are left out of the figures above.

Details

Common questions

Is the Establishment Labs Holdings Inc. CEO selling stock?

No. Filippo Caldini reported no open-market sales in the past 12 months.

Why are Establishment Labs Holdings Inc. insiders selling?

Filings rarely give a reason, and we don't guess at one. What they show is how the sales were made: 100% of sales by value ran under 10b5-1 trading plans disclosed in the filings. A trading plan schedules sales in advance.

Are any Establishment Labs Holdings Inc. insiders buying?

No. Officers and directors reported no purchases in the past 12 months.

The evidence

Who sold1 officer or director: amount, % of holdings, trading plan
Who soldAmount% of holdingsTrading plan
Quiros Chacon
Director
$22.9M
330K shares
Not confirmed
share of stake is being verified. Why
Disclosed plan

Outside holder, reported separately: JW Asset Management, LLC (a 10% owner, not part of management). Sold $14.0M (192K shares) from Nov 6, 2025 to May 28, 2026. Latest filing

The full ownership picture0 of 10 officers and directors confirmed

Vested shares across all share classes, held directly and through trusts, LLCs and family members, as reported on SEC Forms 3, 4 and 5. Unvested awards and options are never counted as owned shares.

InsiderHeld Oct 16, 2025SoldHeld Oct 16, 2026Still held
Quiros Chacon
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. See the filing Sales and other transactions for Quiros Chacon are complete.
Director
n/a−330Kn/an/a
Vesting, gifts, unvested awards and holding lines for Quiros Chacon

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Quiros Chacon are complete; balances and unit counts will be added when the check is finished.

−50Kgifted (net of own trusts)

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
19,236$49.25Mar 6, 2034$455K
14,906$36.46May 14, 2035$543K

Estimate: options held × ($72.89 − strike price), using the most recent insider trade price on Form 4 (May 28, 2026), not a market close.

Nicholas Lewin
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Nicholas Lewin are complete.
Director
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for Nicholas Lewin

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Nicholas Lewin are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
36,027$36.46May 14, 2035$1.3M
19,561$66.28Apr 24, 2036$129K

Estimate: options held × ($72.89 − strike price), using the most recent insider trade price on Form 4 (May 28, 2026), not a market close.

Edward Schutter
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Edward Schutter are complete.
Director
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for Edward Schutter

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Edward Schutter are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)
Filippo Caldini
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Filippo Caldini are complete.
Chief Executive Officer, Director
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for Filippo Caldini

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Filippo Caldini are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)
−682withheld by the company for taxes

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
17,910$44.06Aug 20, 2034$516K
30,333$34.82Mar 13, 2035$1.2M
12,009$36.46May 14, 2035$437K
24,879$76.23Feb 18, 2036$0

Estimate: options held × ($72.89 − strike price), using the most recent insider trade price on Form 4 (May 28, 2026), not a market close.

Bryan Slotkin
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Bryan Slotkin are complete.
Director
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for Bryan Slotkin

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Bryan Slotkin are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)
Ann Custin
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Ann Custin are complete.
Director
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for Ann Custin

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Ann Custin are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)
Leslie Gillin
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Leslie Gillin are complete.
Director
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for Leslie Gillin

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Leslie Gillin are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)
Samuel Mansbach
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Samuel Mansbach are complete.
General Counsel and CCO
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for Samuel Mansbach

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Samuel Mansbach are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)
−657withheld by the company for taxes

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
7,691$49.25Mar 6, 2034$182K
13,998$34.82Mar 13, 2035$533K
7,131$74.60Feb 16, 36$0

Estimate: options held × ($72.89 − strike price), using the most recent insider trade price on Form 4 (May 28, 2026), not a market close.

Cassandra Harris
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Cassandra Harris are complete.
Chief Financial Officer
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for Cassandra Harris

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Cassandra Harris are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options heldStrike priceExpiresIntrinsic value (estimate)
12,877$74.60Feb 16, 2036$0

Estimate: options held × ($72.89 − strike price), using the most recent insider trade price on Form 4 (May 28, 2026), not a market close.

Taylor Harris
!
Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. See the filing Sales and other transactions for Taylor Harris are complete.
Director
n/a0n/an/a
Vesting, gifts, unvested awards and holding lines for Taylor Harris

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Taylor Harris are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Holdings and share of stake for Establishment Labs Holdings Inc. are being verified, so no balances, unit counts or percentages are shown. Sales, proceeds, plan and tax status, titles and dates come straight from individual filings.

What explains the selling$22.9M of sales by plan status, purpose, seller and month

Officer and director open-market sales: $22.9M across 330,000 shares. Plan status and stated purpose are separate questions, and a sale can have both.

By plan status

Taxes

1,339 shares ($95K) were withheld by the company for taxes, which isn't a market sale.

SellerShares soldProceedsUnder a disclosed planShare of totalSales dates
Quiros Chacon
Director
330K$22.9M100%100%Mar 23, 2026 to May 6, 2026

Sales by month

MonthSale proceedsDisclosed planTo cover taxesNo plan disclosed
Oct 2025$0$0$0$0
Nov 2025$0$0$0$0
Dec 2025$0$0$0$0
Jan 2026$0$0$0$0
Feb 2026$0$0$0$0
Mar 2026$2.3M$2.3M$0$0
Apr 2026$7.4M$7.4M$0$0
May 2026$13.2M$13.2M$0$0
Jun 2026$0$0$0$0
Jul 2026$0$0$0$0
Aug 2026$0$0$0$0
Sep 2026$0$0$0$0
Oct 2026$0$0$0$0
Is this normal? Selling year by year5 earlier years to compare with

More than usual: $22.9M sold, after almost none in the past 5 years. 1 insider sold; the average is 2 a year.

12 months endingShares soldInsiders who soldProceeds
Oct 16, 2026
Latest 12 months
330K1$22.9M
Oct 16, 2025
1 year earlier
00$0
Oct 16, 2024
2 years earlier
15K1$677K
Oct 17, 2023
3 years earlier
3.8K1$254K
Oct 17, 2022
4 years earlier
00$0
Oct 17, 2021
5 years earlier
241K6$11.0M

Open-market sales (Form 4 code S) by people who were officers or directors, in split-adjusted shares. Earlier years include people who have since left. A sale that an outside holder also reports (a family trust, a fund) is counted with outside holders in every year. Shares, not dollars, are compared, so a change in the stock price doesn't look like a change in selling. Years the filings don't fully cover are shown but left out of the average.

Known gaps and uncertainty10 officers and directors not confirmed

Holdings and share of stake are being verified. Balances, unit counts and every share-of-stake figure for Establishment Labs Holdings Inc. are held back until that check is finished. Sales, proceeds, plan and tax status, titles and dates come straight from individual filings and are complete.

External context: we only cite outside events when a documented connection exists. None is shown for this period.

Sources and methodology301 filings on record, 52 filed in the 12-month period, and how we read them

All 301 Forms 3, 4 and 5 on record for Establishment Labs Holdings Inc. (SEC CIK 1688757), filed from Jul 18, 2018 to Oct 2, 2026; 52 of them were filed in the 12 months this page covers, retrieved from SEC EDGAR on Oct 16, 2026. Prices are the ones reported in each filing, often weighted averages.

Holdings. Each holding line (a share class plus an owner, such as a trust or LLC) carries its last reported balance forward. Entities first reported during the period start at zero, so transfers between an insider's own trusts don't count as selling. Lines not reported for three years or more are listed separately and left out of totals.

Sales. A sale counts as under a 10b5-1 plan if its footnote cites one or the filing's Rule 10b5-1 box is checked, and as tax-related if its footnote cites tax obligations or sell-to-cover. Shares withheld by the company for taxes are listed separately. Sales with neither attribute are labeled "no plan disclosed".

Full methodology

Former or inactive filers (12)No filing in 18 months; last reported balances, not in any total
NameLast filedLast reported balance
Raj DenhoyApr 4, 202523,348 shares, last reported balance as of Mar 13, 2025
Dennis CondonJan 3, 20259,385 shares, last reported balance as of Dec 31, 2024
Paul RodioMar 29, 2023No balance on record
Lisa ColleranJun 22, 202245,276 shares, last reported balance as of Jun 17, 2022
Pratip DastidarApr 12, 20226,811 shares, last reported balance as of Apr 10, 2022
Lisa GershAug 9, 2021No balance on record
Roberto De MezervilleJun 1, 2021107,844 shares, last reported balance as of May 21, 2021
Renee GaetaMay 21, 2021No balance on record
Santos DadaFeb 17, 202199,660 shares, last reported balance as of Jan 13, 2021
David HungMay 27, 2020No balance on record
Eddie de OliveiraApr 29, 20199,056 shares, last reported balance as of Jul 23, 2018
Allan WeinsteinJul 18, 2018No balance on record

Spotted something wrong on this page? Report an error. We check every report against the SEC filing and list what we fix in the corrections log.